Details of the Drug

General Information of Drug (ID: DMNUDO0)

• Drug Name: Voyager-V1
• Synonyms: VSV-IFNBeta-NIS

Indication

Disease Entry	ICD 11	Status	REF
Hepatocellular carcinoma	2C12.02	Phase 2	[1]
Melanoma	2C30	Phase 2	[1]
Non-small-cell lung cancer	2C25	Phase 2	[1]

• Drug Type: Oncolytic virus therapy
• Cross-matching ID: TTD ID: D4AGB6
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT04291105) Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients. U.S. National Institutes of Health.